Drug Database
Back to search

United Kingdom· GB-APID-4415111000001109

Tarivid 200mg/100ml solution for infusion bottles

A ofloxacin product containing ofloxacin, registered in United Kingdom by Sanofi. The same ATC class is registered in 10 of our 19 countries.

ATC J01MA01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedTarivid 200mg/100ml solution for infu…ATCJ01MA01REGISTER NO.GB-APID-4415111000001…PACKS LISTED1CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ofloxacinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ofloxacin is registered in 10 of 19 countries.

Countries holding a registration under ATC J01MA01 (ofloxacin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 6 of them publish a price we can compare per daily dose
Search ofloxacin products by name

Ofloxacin · ATC J01MA01

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Ofloxacin
Manufacturer
Sanofi
Country
United Kingdom (GB)
ATC code
J01MA01
ATC class
Ofloxacin
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5013487182645

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

596 interactions on record for ofloxacin.

Graded by severity as the source publishes them — 86 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ofloxacin against other medicinesHow interaction checks work

Ofloxacin · interactions on record

596 records

  • 86 severe
  • 216 moderate
  • 51 minor
  • 170 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • PrednisoloneA07EA01severe

73 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ofloxacin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ofloxacin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Floxal, Floxal Edo
  • Belgium · Trafloxal, Trafloxal Edo
  • Bulgaria · Медофлоксин, Офлоксацин Дра
  • Cyprus · Cilox, Medofloxine
  • Czechia · Floxal, Ofloxacin Unimed Pharma
  • Germany · Floxal, Floxal Edo
  • Estonia · Medofloxine, Ofloxin
  • Spain · Exocin, Oflovir
  • Finland · Exocin
  • France · Exocine, Monoflocet
  • Greece · Exocin, Oxatrex
  • Croatia · Uniflox
  • Hungary · Floxal, Grenis-Oflo
  • Ireland · Exocin
  • Italy · Dunaflot, Exocin
  • Lithuania · Ofloxin, Uniflox
  • Luxembourg · Ofloxa-Vision Kombi-Packung, Visioflox
  • Latvia · Ofloxin, Uniflox
  • Malta · Uniflox Unimed Pharma
  • Netherlands · Ofloxacine 200 Pch, Ofloxacine 400 Pch
  • Poland · Floxal, Oflodinex
  • Portugal · Audret, Bioquil
  • Romania · Floxal, Ofloxacină Laropharm
  • Sweden · Ofloxacin Mibe
  • Slovakia · Medofloxine, Ofloxin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bbab07ca-4d2b-49d7-b2a8-db63c40d258f
GET /v1/drugs/bbab07ca-4d2b-49d7-b2a8-db63c40d258f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "4415111000001109",
  "desc": "Tarivid 200mg/100ml solution for infusion bottles (Sanofi)",
  "form": "Solution for infusion",
  "vpid": "38752711000001101",
  "source": "dmd",
  "vtm_id": "776973005",
  "strength": "2 mg",
  "substance": "Ofloxacin",
  "ingredient": "Ofloxacin hydrochloride",
  "supplier_code": "9190711000001101"
}
API referenceMCP serverPlans

See everything about ofloxacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console